Duloxetine Delayed-Release Capsules, 20 mg, Rx Only, 60 capsules, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807, Made in India, NDC 27241-097-06. Recall
Recall Date
May 13, 2026
Company
Ajanta Pharma Ltd.
Source
FDA
Units
117,168 packs
Reason: CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12-month and 18-month long-term stability intervals.
Official FDA recall noticeInformation is from official FDA notices. Do not stop taking any medication without consulting your doctor or pharmacist first — the risks of stopping may be greater than the risk from the recalled product.
Description
CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12-month and 18-month long-term stability intervals.
Reason for Recall
CGMP Deviations: Presence of N-nitroso-Duloxetine impurity above FDA recommended limit of 0.83 ppm, identified at the 12-month and 18-month long-term stability intervals.
What Should I Do?
Quantity: 117,168 packs
5-step guide to help you action required this recalled product. Click Start Remediation to track your progress.
+2 more steps…
Last updated May 19, 2026
Injured by a recalled product?
Our legal partners offer free consultations for recall victims.
Stay Informed
Weekly recall digest — free, no spam.